- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 80.42M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $449.8M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $449.79M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $170.93M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $167.79M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $163.97M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $288.27M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.14B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.07B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.77B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.7B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.32B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.4B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.21B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.29B |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $375.05M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $371.03M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 83.96M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $154.76M |
| Capex | Q1 2025 · Mar 31, 2024 | $30.27M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $198.59M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.57B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.48B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $2.81 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $2.84 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $92.02M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $52.64M |
| Net Income | Q1 2025 · Mar 31, 2024 | $235.58M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $298.96M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $593.07M |
| Revenue | Q1 2025 · Mar 31, 2024 | $964.1M |